• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer.miR-141、miR-200c、miR-30b表达与膀胱癌临床病理特征的评估
Int J Mol Cell Med. 2015 Winter;4(1):32-9.
2
Association between tissue miR-141, miR-200c and miR-30b and bladder cancer: a matched case-control study.组织中miR-141、miR-200c和miR-30b与膀胱癌的关联:一项配对病例对照研究。
Urol J. 2015 Feb 22;12(1):2010-3.
3
Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue.评估膀胱癌组织中锌指 E 盒结合同源盒 1 和转化生长因子-β2 的表达,并与健康相邻组织进行比较。
Investig Clin Urol. 2017 Mar;58(2):140-145. doi: 10.4111/icu.2017.58.2.140. Epub 2017 Feb 15.
4
Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.膀胱癌中MicroRNA-99a和MicroRNA-205表达水平的评估
Int J Mol Cell Med. 2017 Spring;6(2):87-95. doi: 10.22088/acadpub.BUMS.6.2.3. Epub 2017 Jul 8.
5
Expression profile of microrna-145 in urothelial bladder cancer.miRNA-145 在尿路上皮膀胱癌中的表达谱。
Int Braz J Urol. 2013 Jan-Feb;39(1):95-101; discussion 102. doi: 10.1590/S1677-5538.IBJU.2013.01.12.
6
Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.抑癌 microRNA-139-5p 通过靶向连接蛋白 43 抑制膀胱癌细胞系 ECV-304 的特性。
Chin Med J (Engl). 2019 Oct 5;132(19):2354-2361. doi: 10.1097/CM9.0000000000000455.
7
microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.大量膀胱肿瘤中 microRNA 表达谱:鉴定与肌层浸润性膀胱癌侵袭性相关的 3 个 miRNA 特征。
Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.
8
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.微小RNA-200c和微小RNA-31调节浆液性卵巢癌的增殖、集落形成、迁移和侵袭。
J Ovarian Res. 2015 Aug 12;8:56. doi: 10.1186/s13048-015-0186-7.
9
MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.微小RNA-200c通过直接靶向RECK促进膀胱癌细胞的迁移和侵袭。
Onco Targets Ther. 2016 Aug 16;9:5091-9. doi: 10.2147/OTT.S101067. eCollection 2016.
10
A MicroRNA expression profile defining the invasive bladder tumor phenotype.一种定义浸润性膀胱癌表型的 microRNA 表达谱。
Urol Oncol. 2011 Nov-Dec;29(6):794-801.e1. doi: 10.1016/j.urolonc.2009.08.024. Epub 2009 Nov 27.

引用本文的文献

1
Development of a microRNA-Based age estimation model using whole-blood microRNA expression profiling.利用全血微小RNA表达谱开发基于微小RNA的年龄估计模型。
Noncoding RNA Res. 2025 Mar 3;12:81-91. doi: 10.1016/j.ncrna.2025.03.003. eCollection 2025 Jun.
2
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.膀胱癌患者生存时间估计的 microRNA 特征。
Sci Rep. 2022 Mar 9;12(1):4141. doi: 10.1038/s41598-022-08082-7.
3
The analysis of a ceRNA network and the correlation between lncRNA, miRNA, and mRNA in bladder cancer.膀胱癌中ceRNA网络及lncRNA、miRNA与mRNA之间的相关性分析。
Transl Cancer Res. 2020 Feb;9(2):869-881. doi: 10.21037/tcr.2019.12.27.
4
MicroRNAs miR-4535 and miR-1915-5p in amniotic fluid as predictive biomarkers for chorioamnionitis.羊水内的微小RNA miR-4535和miR-1915-5p作为绒毛膜羊膜炎的预测生物标志物
Future Sci OA. 2021 Feb 15;7(5):FSO686. doi: 10.2144/fsoa-2021-0006.
5
Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.循环微小RNA-141在上皮性卵巢癌中的表达
Malays J Med Sci. 2020 Dec;27(6):27-38. doi: 10.21315/mjms2020.27.6.4. Epub 2020 Dec 1.
6
Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review).miR-30b在癌症、心血管疾病和代谢紊乱中的作用及调控机制(综述)
Exp Ther Med. 2021 Jan;21(1):44. doi: 10.3892/etm.2020.9475. Epub 2020 Nov 17.
7
Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach.基于微小RNA方法的膀胱癌患者预后分层
Cancers (Basel). 2020 Oct 26;12(11):3133. doi: 10.3390/cancers12113133.
8
Genetic and molecular biology of bladder cancer among Iranian patients.伊朗患者膀胱癌的遗传和分子生物学。
Mol Genet Genomic Med. 2020 Jun;8(6):e1233. doi: 10.1002/mgg3.1233. Epub 2020 Apr 6.
9
Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.生物信息学分析筛选膀胱癌肿瘤微环境中的关键预后基因。
Biomed Res Int. 2020 Feb 17;2020:6034670. doi: 10.1155/2020/6034670. eCollection 2020.
10
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.循环 miR-30b-5p 的过表达可识别晚期乳腺癌。
J Transl Med. 2019 Dec 30;17(1):435. doi: 10.1186/s12967-019-02193-y.

本文引用的文献

1
Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.miRNAs 和 ZEB1、ZEB2 的表达与膀胱尿路上皮乳头状肿瘤的组织病理学分级相关。
Virchows Arch. 2014 Feb;464(2):213-20. doi: 10.1007/s00428-013-1518-x. Epub 2013 Dec 4.
2
miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.miRNA 谱分析鉴定膀胱癌诊断和临床结局的候选 mirnas。
J Mol Diagn. 2013 Sep;15(5):695-705. doi: 10.1016/j.jmoldx.2013.05.008. Epub 2013 Aug 12.
3
Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?血清中的循环微小RNA:膀胱癌患者的新型生物标志物?
World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25.
4
Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.根据 microRNA 表达谱定义的膀胱尿路上皮癌的分期、分级和行为。
J Urol. 2012 Nov;188(5):1951-6. doi: 10.1016/j.juro.2012.07.004. Epub 2012 Sep 20.
5
Infiltration related miRNAs in bladder urothelial carcinoma.膀胱尿路上皮癌中与浸润相关的微小RNA
J Huazhong Univ Sci Technolog Med Sci. 2012 Aug;32(4):576-580. doi: 10.1007/s11596-012-0099-2. Epub 2012 Aug 11.
6
Secretory miRNAs as novel cancer biomarkers.分泌型微小RNA作为新型癌症生物标志物
Biochim Biophys Acta. 2012 Aug;1826(1):32-43. doi: 10.1016/j.bbcan.2012.03.001. Epub 2012 Mar 13.
7
miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.miR-143、miR-222 和 miR-452 可用作膀胱癌的肿瘤分层和非侵入性诊断生物标志物。
Am J Pathol. 2012 May;180(5):1808-15. doi: 10.1016/j.ajpath.2012.01.034. Epub 2012 Mar 15.
8
Expression of microRNAs in the urine of patients with bladder cancer.膀胱癌患者尿液中 microRNAs 的表达。
Clin Genitourin Cancer. 2012 Jun;10(2):106-13. doi: 10.1016/j.clgc.2012.01.001. Epub 2012 Mar 3.
9
[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].[欧洲泌尿外科学会膀胱非肌层浸润性尿路上皮癌指南,2011年更新版]
Actas Urol Esp. 2012 Jul-Aug;36(7):389-402. doi: 10.1016/j.acuro.2011.12.001. Epub 2012 Mar 2.
10
Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.细胞周期蛋白依赖性激酶 4 是微小 RNA-195 介导的膀胱癌细胞周期阻滞的新靶点。
FEBS Lett. 2012 Feb 17;586(4):442-7. doi: 10.1016/j.febslet.2012.01.027. Epub 2012 Jan 28.

miR-141、miR-200c、miR-30b表达与膀胱癌临床病理特征的评估

Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer.

作者信息

Mahdavinezhad Ali, Mousavi-Bahar Seyed Habibollah, Poorolajal Jalal, Yadegarazari Reza, Jafari Mohammad, Shabab Nooshin, Saidijam Massoud

机构信息

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Urology and Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

出版信息

Int J Mol Cell Med. 2015 Winter;4(1):32-9.

PMID:25815280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4359703/
Abstract

Bladder cancer (BC) ranks the second most common genitourinary tract malignant tumor with high mortality and 70% recurrence rate worldwide. MiRNAs expression has noticeable role in bladder tumorigenesis. The purpose of this study was to assess miR-200c, miR-30b and miR-141 in tissue samples of patients with BC and healthy adjacent tissue samples and their association with muscle invasion, grade and the size of the tumor. Transurethral resection tissue samples were collected from thirty- five newly diagnosed untreated patients with BC from 2013 to 2014. The control group consisted of adjacent normal urothelium. All samples, observed by two pathologists, were diagnosed transitional cell carcinomas (TCC) with the proportion of tumor cells greater than 80%. Total RNA including miRNAs was extracted from about 50 mg tissue samples by applying TRIzol reagent. 2((-ΔΔ CT)) method was used to calculate relative quantification of miRNA expression. Two of 35 patients were females and the other 33 were males. Invasion to bladder muscle was observed in 13 (37%) cases. MiR-141, miR-200-c and miR30-b were up-regulated in 91%, 79% and 64% of malignant tissues, respectively. Down-regulation of miR-141 had a strong association with muscle invasion (P= 0.017). Significant inverse correlation between grading and miRNA-141 level was observed (P= 0.043).

摘要

膀胱癌(BC)是全球第二大常见的泌尿生殖系统恶性肿瘤,死亡率高,复发率达70%。微小RNA(miRNA)表达在膀胱肿瘤发生过程中具有显著作用。本研究旨在评估BC患者组织样本及健康相邻组织样本中的miR-200c、miR-30b和miR-141,以及它们与肌肉浸润、肿瘤分级和大小的关系。2013年至2014年,从35例新诊断的未经治疗的BC患者中收集经尿道切除组织样本。对照组为相邻正常尿路上皮。所有样本经两名病理学家观察,均诊断为移行细胞癌(TCC),肿瘤细胞比例大于80%。使用TRIzol试剂从约50mg组织样本中提取包括miRNA在内的总RNA。采用2^(-ΔΔCT)法计算miRNA表达的相对定量。35例患者中2例为女性,其余33例为男性。13例(37%)观察到膀胱肌肉浸润。miR-141、miR-200-c和miR30-b在恶性组织中的上调率分别为91%、79%和64%。miR-141的下调与肌肉浸润密切相关(P = 0.017)。观察到分级与miRNA-141水平之间存在显著负相关(P = 0.043)。